Top Markets
Coin of the day
The Greater Cannabis Company, Inc. The Greater Cannabis Company, Inc.

The Greater Cannabis Company, Inc.

GCAN
Pozycja w akcjach #40153
The Greater Cannabis Company, Inc. engages in the development and... The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.
Cena akcji
$0.2301
Ostatnia synchronizacja: 2026-08-12
Kapitalizacja rynkowa
$228.81K
Zmiana (1 dzień)
-17.82%
Zmiana (1 rok)
95,775.00%
Kraj
US
Handel The Greater Cannabis Company, Inc. (GCAN)

Kategoria

Historia stopy dywidendy dla The Greater Cannabis Company, Inc. (GCAN)
Stopa dywidendy (TTM) dla The Greater Cannabis Company, Inc. (symbol akcji: GCAN) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla The Greater Cannabis Company, Inc. (GCAN) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji